Literature DB >> 581119

Plasma levels of testosterone in bulls. Response to repeated HCG injections.

A Sundby, P A Torjesen.   

Abstract

Administration of 6000 IU HCG to 4 bulls was followed by an elevation of plasma testosterone lasting for 9-13 days. When HCG administration was repeated, the testosterone response was shortened to 4-6 days in 3 bulls due to the formation of antibodies against HCG. The appearance of HCG antibodies coincided with a sharp decrease in the plasma testosterone level, indicating that Leydig cells have to be under continuous HCG stimulation to maintain increased testosterone production. No antibody against bovine LH was detected in the plasma samples containing antibodies against HCG. In one bull the response following the second HCG injection was similar to the plasma testosterone pattern following the first. No antibodies against HCG were found in this bull. Five bulls received 750 IU HCG twice. Following the period with elevated plasma testosterone levels, subnormal levels were observed after both injections. One injection led to decreased levels without development of antibodies against HCG while the second HCG injection led to subnormal testosterone levels concomitant with measurable antibodies against HCG.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 581119     DOI: 10.1530/acta.0.0880787

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  3 in total

1.  Alveld-producing saponins. I. Chemical studies.

Authors:  L Ceh; J G Hauge
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

2.  The immediate effect of HCG upon plasma testosterone levels in the bull.

Authors:  A Sundby
Journal:  Acta Vet Scand       Date:  1981       Impact factor: 1.695

3.  What Happens in Male Dogs after Treatment with a 4.7 mg Deslorelin Implant? II. Recovery of Testicular Function after Implant Removal.

Authors:  Sabrina Stempel; Hanna Körber; Larena Reifarth; Gerhard Schuler; Sandra Goericke-Pesch
Journal:  Animals (Basel)       Date:  2022-09-23       Impact factor: 3.231

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.